"Personalizing" academic medicine: opportunities and challenges in implementing genomic profiling

Translational Research

Volumn 154, Issue 6, 2009, Pages 288-294

  Tweardy, David J ^a   Belmont, John W ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; AZATHIOPRINE; CAPECITABINE; CLOPIDOGREL; CYTOCHROME P450 2D; FLUOROURACIL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IRINOTECAN; ISONIAZID; MERCAPTOPURINE; OXIDOREDUCTASE; PAROXETINE; RIFAMPICIN; SULFALAZINE; TACROLIMUS; TEGAFUR; TIOGUANINE; WARFARIN;

CLINICAL RESEARCH; CORONARY ARTERY DISEASE; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC VALUE; DRUG METABOLISM; GENE EXPRESSION PROFILING; GENE MUTATION; GENETIC COUNSELING; GENETIC PROCEDURES; GENETIC RISK; GENETIC SCREENING; GENETIC VARIABILITY; GENOMICS; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEDICAL RECORD; MEDICINE; PATIENT CARE; PERSONAL GENOME PROFILING; PERSONALIZED MEDICINE; PHARMACOGENOMICS; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; QUALITATIVE VALIDITY; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 70449463493     PISSN: 19315244     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trsl.2009.09.008     Document Type: Review

References (20)

1. Orr N., and Chanock S. Common genetic variation and human disease. Adv Genet 62 (2008) 1-32
2. Brautbar A., Ballantyne C.M., Lawson K., et al. Impact of adding a single allele in the 9p21 locus to traditional risk factors on reclassification of coronary heart disease risk and implications for lipid-modifying therapy in the atherosclerosis risk in communities study. Circ Cardiovasc Genet 2 (2009) 279-285
3. Grossman I. ADME pharmacogenetics: current practices and future outlook. Expert Opin Drug Metab Toxicol 5 (2009) 449-462
4. Kweekel D., Guchelaar H.J., and Gelderblom H. Clinical and pharmacogenetic factors associated with irinotecan toxicity. Cancer Treat Rev 34 (2008) 656-669
5. Sahasranaman S., Howard D., and Roy S. Clinical pharmacology and pharmacogenetics of thiopurines. Eur J Clin Pharmacol 64 (2008) 753-767
6. Telenti A., and Zanger U.M. Pharmacogenetics of anti-HIV drugs. Annu Rev Pharmacol Toxicol 48 (2008) 227-256
7. Limdi N.A., and Veenstra D.L. Warfarin pharmacogenetics. Pharmacotherapy 28 (2008) 1084-1097
8. Baird P.A., Anderson T.W., Newcombe H.B., and Lowry R.B. Genetic disorders in children and young adults: a population study. Am J Hum Genet 42 (1988) 677-693
9. Riepe F.G., van Bemmelen M.X., Cachat F., et al. Revealing a subclinical salt-losing phenotype in heterozygous carriers of the novel S562P mutation in the alpha subunit of the epithelial sodium channel. Clin Endocrinol 70 (2009) 252-258
10. Smirnov D.A., and Cheung V.G. ATM gene mutations result in both recessive and dominant expression phenotypes of genes and microRNAs. Am J Hum Genet 83 (2008) 243-253
11. Zimran A., Neudorfer O., and Elstein D. The glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews. N Engl J Med 352 (2005) 728-731
12. Bresso F., Askling J., Astegiano M., et al. Potential role for the common cystic fibrosis DeltaF508 mutation in Crohn's disease. Inflamm Bowel Dis 13 (2007) 531-536
13. Houlden H., Groves M., Miedzybrodzka Z., et al. New mutations, genotype phenotype studies and manifesting carriers in giant axonal neuropathy. J Neurol Neurosurg Psychiatry 78 (2007) 1267-1270
14. Khan A.O., Aldahmesh M.A., and Meyer B. Recessive congenital total cataract with microcornea and heterozygote carrier signs caused by a novel missense CRYAA mutation (R54C). Am J Ophthalmol 144 (2007) 949-952
15. Qian J., Deveault C., Bagga R., Xie X., and Slim R. Women heterozygous for NALP7/NLRP7 mutations are at risk for reproductive wastage: report of two novel mutations. Hum Mutat 28 (2007) 741
16. Rahman N., and Scott R.H. Cancer genes associated with phenotypes in monoallelic and biallelic mutation carriers: new lessons from old players. Hum Mol Genet 16 (2007) R60-R66
17. Rantamaki M., Luoma P., Virta J.J., et al. Do carriers of POLG mutation W748S have disease manifestations?. Clin Genet 72 (2007) 532-537
18. Slatkin M., and Rannala B. The sampling distribution of disease-associated alleles. Genetics 147 (1997) 1855-1861
19. Maresso K., and Broeckel U. Genotyping platforms for mass-throughput genotyping with SNPs, including human genome-wide scans. Adv Genet 60 (2008) 107-139
20. Wheeler D.A., Srinivasan M., Egholm M., et al. The complete genome of an individual by massively parallel DNA sequencing. Nature 452 (2008) 872-876